Summit examines U.S. drug supply chain as security priority

Aug 04, 2020 - 03:25 PM
prescription-drug-medicine-data

The AHA, American Medical Association, American Society of Health-System Pharmacists, and United States Pharmacopeia last week convened a virtual summit to examine the resilience of the U.S. pharmaceutical supply chain in light of the current state of global pharmaceutical manufacturing.

Representatives from clinician groups, industry, the supply chain and public sector discussed global pharmaceutical manufacturing as a national security priority, noting that the rapid global outbreak of COVID-19 and its negative ripple effect on patients’ access to critical medicines have called attention to increasing concerns about the stability and security of the U.S. drug supply.

Summit topics included advanced technologies such as continuous manufacturing and 3-D printing, which may help produce oral and parenteral drugs more efficiently; the role of public-private partnerships in developing and disseminating new technologies; diversifying the global supply chain; and creating a list of essential medicines to produce in the U.S.

The organizers plan to release a report outlining the summit proceedings later this year.

Related News Articles

Headline
FDA proposes drug registration changes to boost supply chain transparency
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for…
Headline
AHA comments on proposed tariffs on medications, medical devices
The AHA today sent a letter to the Office of the United States Trade Representative to ask that medications, medical devices and other healthcare…
Headline
HHS to end emergency authorization for COVID-19 drugs, medical devices 
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
ASPR launches competition on improving domestic production of critical medical supplies
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
USTR proposes additional tariffs on certain nations, citing failure to impose or enforce ban on forced labor
The U.S. Trade Representative yesterday announced plans to impose additional tariffs on goods from certain nations that it said had lacked or failed…